ACTRN12611000908932已完成未知
The clinical pharmacokinetics of metformin in patients with type 2 diabetes
Prof Richard Day0 个研究点目标入组 120 人开始时间: 2011年8月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Patients with type 2 diabetes and taking metformin.
排除标准
- •Patients unable to provide informed consent to participate in the study.
研究者
相似试验
已完成
4 期
The safety and disposition of metformin in people with liver diseaseChronic liver diseaseMetabolic and Endocrine - DiabetesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12619001292167St Vincent's Hospital, Sydney24
已完成
不适用
The safety and disposition of metformin in people with liver disease and diabetes already treated with metformiChronic liver diseaseMetabolic and Endocrine - DiabetesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonDiabetesACTRN12619001348145St Vincent's Hospital, Sydney34
已完成
1 期
The use of metformin in patients with moderate to severe renal failure and type 2 diabetesType 2 Diabetes mellitusMetabolic and Endocrine - DiabetesRenal and Urogenital - Kidney diseaseChronic Kidney DiseaseACTRN12616001248459Dr Ajith Dissanayake18
招募中
4 期
Can metformin be safely used in patients with heart failure?Cardiovascular - Other cardiovascular diseasesChronic heart failureACTRN12617001418369St Vincent's Hospital Sydney50
已完成
不适用
Pharmacokinetics and Pharmacodynamics of metformin in patients with type 2 diabetes and renal impairmentDiabetic NephropathyNL-OMON38577niversitair Medisch Centrum Groningen110